Dr. Clay Siegall is the founder and CEO of Seattle Genetics. Seattle Genetics is a biotech firm that specializes in developing different types of therapy drugs for certain diseases that haven’t had much luck with treatment in the past few decades. Dr. Siegall has two degrees, a B.S. in zoology from the University of Maryland and a Ph.D. in genetics from George Washington University. Dr. Siegall founded Seattle Genetics in 1998 and has founded and created a many prescription drugs since then. Seattle Genetics has flourished since their startup and has made a large contribution to medicine today.
In a recent interview with Inspirery, Dr. Clay Siegall answered some questions about his business. An important question that was asked in his interview was How did you get started in this business and what inspired you to start this business? He stated that he was always interested in medicine and the power of technology. He also went on to say how he saw the effect of cancer on someone close to him and it was brutal. Another question asked How do you make money and how long did it take for you to become profitable? Dr. Siegall replied with a lengthy description that goes on to talk about how difficult it is to get a drug approved, however once you get your foot in the door, then the money starts rolling in.
Dr. Siegall has secured more than $675 million through private and public financings. Before Seattle Genetics Dr. Siegall was with the Bristol-Myers Squibb Pharmaceutical Research Institute for about 8 years and before that he was at the National Cancer Institute for about 3 years. He also serves on the Board of Directors of Alder BioPharmaceuticals, which is a private biotech company. As you can see Dr. Siegall is very experienced in his field of research and has contributed plenty to the field of science and the communities as well as the world are grateful for everything he has done so far.